These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 9297083)
1. [Genetic immunization against tick-borne encephalitis virus]. Mitrofanova EE; Bakhvalova VN; Dobrikova EIu; Pap VA; Morozova OV Mol Biol (Mosk); 1997; 31(3):403-6. PubMed ID: 9297083 [No Abstract] [Full Text] [Related]
2. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus. Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091 [TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis. Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392 [TBL] [Abstract][Full Text] [Related]
6. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus. Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085 [TBL] [Abstract][Full Text] [Related]
7. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model. Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903 [TBL] [Abstract][Full Text] [Related]
8. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. Aberle JH; Aberle SW; Allison SL; Stiasny K; Ecker M; Mandl CW; Berger R; Heinz FX J Immunol; 1999 Dec; 163(12):6756-61. PubMed ID: 10586074 [TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge. Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605 [TBL] [Abstract][Full Text] [Related]
10. Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice. Omori-Urabe Y; Yoshii K; Ikawa-Yoshida A; Kariwa H; Takashima I Microbiol Immunol; 2011 Dec; 55(12):893-7. PubMed ID: 22004565 [TBL] [Abstract][Full Text] [Related]
11. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis. Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399 [TBL] [Abstract][Full Text] [Related]
12. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis]. Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575 [TBL] [Abstract][Full Text] [Related]
13. [Expression of the NS1 gene of tick-borne encephalitis virus in gram-negative bacteria from the mouse nasopharynx]. Morozova OV; Maksimova TG; Popova RV; Martsinkevich ON; Bakhvalova VN Mol Biol (Mosk); 2001; 35(1):157-62. PubMed ID: 11234376 [TBL] [Abstract][Full Text] [Related]
14. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Pletnev AG Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811 [TBL] [Abstract][Full Text] [Related]
15. [The possibility of preparing a live vaccine against tick-borne encephalitis from Malay langat virus TP-21]. Il'enko VI; Platonov VG; Prozorova IN; Smorodintsev AA Tr Inst Im Pastera; 1989; 65():126-32. PubMed ID: 2560847 [No Abstract] [Full Text] [Related]
16. [Laboratory methods of controlling immunogenicity of vaccines against tick-borne encephalitis]. Sokolova ED Tr Inst Im Pastera; 1989; 65():90-8. PubMed ID: 2560849 [No Abstract] [Full Text] [Related]
17. A novel recombinant adenovirus vector expressing a flavivirus non-structural protein protects against lethal flavivirus challenge. Jacobs SC Clin Sci (Lond); 1993 Aug; 85(2):117-22. PubMed ID: 8403779 [No Abstract] [Full Text] [Related]
18. [Prospects for developing a live vaccine against tick-borne encephalitis]. Kamalov II; Sokolova ED; Denisova EIu Tr Inst Im Pastera; 1989; 65():98-120. PubMed ID: 2516926 [No Abstract] [Full Text] [Related]
19. [The significance of humoral immunity in post-vaccination resistance of mice to tick-borne encephalitis]. Nikonova AN; Rozhkova LV; Sokolova ED Tr Inst Im Pastera; 1989; 65():84-90. PubMed ID: 2560848 [No Abstract] [Full Text] [Related]
20. Studies on the immunizing potency of tick-borne encephalitis vaccines. Gall W Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562 [No Abstract] [Full Text] [Related] [Next] [New Search]